Providers utilize business intelligence to monitor referral patterns and collaborate with clinicians who order their services. Such analytics tools have also been deployed in the specialty to improve productivity, track patient satisfaction and bolster quality.
The acquisition of SPR Therapeutics will allow Medtronic to expand its portfolio of neuromodulator medical devices. The deal is expected to close in 2027.
These third-party marketers earn commissions from their insurer clients not only upon initial signups but also every time “their” enrollees renew without changing plans.
The agency cited free speech as its reasoning for rescinding the long-standing policy. While in place, the rule barred companies that agreed to settlements with the Securities and Exchange Commission from publicly denying allegations made by regulators.
RadNet Chaiman and CEO Howard Berger, MD, explains why the company has invested tens of millions into DeepHealth to rapidly build up a new business model.
The company made the changes after its manufacturer rebates for insulin were challenged by the Federal Trade Commission. Among other shifts, Optum said 100% of all rebates will be distributed to customers by 2028.
The news comes after the New Hampshire Attorney General's Office issued a report that it objected to the merger on the basis that it violates New Hampshire law.
Of 1,000 patients injected with corticosteroids under fluoroscopic guidance at an academic medical center over a 4½-year period, only 10 experienced serious complications within a year.
More than 40% of Americans are generally OK with the thought of AI reading their chest x-rays. Moreover, some 12.3% are very comfortable with the prospect.
U.S. healthcare is now a solid week into the CT contrast shortage of ’22, and common themes are emerging in adaptations at local hospitals and imaging centers.
The FDA has OK’d the use of MR imaging for patients implanted with an autonomic heart-stimulation device as long as the device’s labeled guidelines are followed at the imaging site.
Lisa Mead, PSO executive director, Strategic Radiology, spoke at the Radiology Business Management Association (RBMA) 2022 meeting on her organization's experience collaborating with a large number of radiology groups.